Biotia Provides Microbial Surveillance for Hospitals
On average, one in 25 people who check in to a hospital get an infection— and one in nine die of that infection. 70% of these cases are caused by antimicrobial resistance pathogens. Studies show that active pathogen surveillance and tailored interventions significantly reduce hospital-acquired infections. However, current approaches to identify pathogens, including culturing and PCR are slow, labor intensive, or limited.
Working across hospitals, we leverage next-generation DNA sequencing, and artificial intelligence, for affordable active surveillance of high risk units and high risk patients to identify and stop pathogens before patients get sick.
To eradicate hospital acquired infections and deploy the leading database of microbes and antimicrobial resistance for global pathogen identification.